UMIN-CTR History

Name:  UMIN ID:


Unique ID issued by UMIN UMIN000015727
Receipt number R000018010
Scientific Title Randomized, controlled trial of the clinical effect of selecrive SGLT2 blocker, ipragliflozin, and DPP-4 blocker in type 2 diabetic patients with NAFLD/NASH.- multicenter study -
Date of disclosure of the study information 2014/11/24
Last modified on 2020/01/12 15:28:22

No. Disposal Last modified on Item of update
1 Insert 2014/11/20 16:40:23
2 Update 2015/03/10 11:28:11 Target sample size
3 Update 2015/03/10 11:32:25 Organization
Organization
Category of Funding Organization
4 Update 2016/06/06 15:15:04 UMIN ID2
5 Update 2016/06/06 15:18:33 Last name of lead principal investigator
Last name of contact person
Last name of contact person
Email
Name of primary person or sponsor
Institute
Organization
Organization
6 Update 2017/05/23 12:14:45 Recruitment status
Last follow-up date
7 Update 2017/11/22 21:18:29 Email
Email1
8 Update 2017/11/22 21:20:06 Recruitment status
9 Update 2019/11/27 22:45:18 Randomization unit
10 Update 2019/11/27 22:51:12 1st name of lead principal investigator
Last name of lead principal investigator
1st name of lead principal investigator
Last name of lead principal investigator
Zip code

Last name of contact person

Last name of contact person
Zip code
Organization
Organization
Address
Address
Tel
Email
11 Update 2020/01/12 15:21:00 Number of participants that the trial has enrolled
Results Delayed
Results Delay Reason
Results Delay Reason
12 Update 2020/01/12 15:28:22 Recruitment status
Date of IRB
Last follow-up date
Date trial data considered complete
Other related information
Other related information